This is an open label compassionate use study of subcutaneously administered methylnaltrexone
(MNTX) in participants with advance medical illness and opioid-induced constipation.
Phase:
N/A
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.